The Latest Breaking News from Disease

Groundbreaking cholesterol jab could revolutionise heart disease care

Leqvio saw users achieve their target cholesterol levels faster than existing treatments

The Independent UK · Aug 30, 2025

Could bananas be the key to fighting heart disease?

IN FULL

The Independent UK · Aug 30, 2025

The simple foods which could drastically cut your risk of dying early

A new study shows that increasing your potassium intake can reduce the risk of heart disease by 24%

The Independent UK · Aug 30, 2025

What can really heal your liver after drinking?

A new study has found lifestyle changes can decrease your chances of alcohol related liver disease by up to 86 per cent

Evening Standard · Aug 29, 2025

Scientists begin to pinpoint what’s in food besides fats, carbs and protein

We consume the chemicals in food every day, but we have little idea what they do

The Independent UK · Aug 29, 2025

Trump administration faces rare bipartisan pushback for firing CDC director

Susan Monarez was reportedly fired by Robert F Kennedy Jr but her lawyers say only Trump himself can remove her

The Guardian - US · Aug 29, 2025

'Aging clocks' tell you how much 'older' you are than your chronological age. How do they work?

"Biological aging tests," also called aging clocks, can predict your risk of age-related disease, disability, early mortality and more — but are they ready for prime time?

LiveScience · Aug 29, 2025

What exactly are you eating? The nutritional ‘dark matter’ in your food

When scientists cracked the human genome in 2003 – sequencing the entire genetic code of a human being – many expected it would unlock the secrets of disease. But genetics explained only about 10% of the risk. The other 90% lies in the environment – and diet plays a huge…

The Conversation · Aug 29, 2025

Legionnaires’ disease outbreak in New York City leaves 7 dead and more than 100 infected

The bacteria that causes Legionnaires’ disease had been discovered in 12 cooling towers on 10 buildings

The Independent UK · Aug 29, 2025

Johnson & Johnson Ends Rheumatoid Arthritis Drug Combo Program

Johnson Johnson (NYSE:JNJ) on Thursday shared topline data from the Phase 2a DAISY proof-of-concept study evaluating the combination of nipocalimab with an anti-tumor necrosis factor alpha (anti-TNFα) therapy in rheumatoid arthritis (RA) patients with refractory disease.

Benzinga · Aug 29, 2025